Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 61

1.
2.

Cilostazol: a review of its use in intermittent claudication.

Chapman TM, Goa KL.

Am J Cardiovasc Drugs. 2003;3(2):117-38. Review.

PMID:
14727939
3.

Cilostazol for intermittent claudication.

Bedenis R, Stewart M, Cleanthis M, Robless P, Mikhailidis DP, Stansby G.

Cochrane Database Syst Rev. 2014 Oct 31;(10):CD003748. doi: 10.1002/14651858.CD003748.pub4. Review.

PMID:
25358850
5.

Cilostazol: a novel treatment option in intermittent claudication.

Cariski AT.

Int J Clin Pract Suppl. 2001 Apr;(119):11-8. Review.

PMID:
11355274
6.

New treatment options in intermittent claudication: the US experience.

Hiatt WR.

Int J Clin Pract Suppl. 2001 Apr;(119):20-7. Review.

PMID:
11355276
7.

Cilostazol: improving walking distance in patients with intermittent claudication.

Collinson DJ, Donnelly R.

Expert Rev Cardiovasc Ther. 2004 Jul;2(4):503-9. Review.

PMID:
15225110
8.

Cilostazol.

Sorkin EM, Markham A.

Drugs Aging. 1999 Jan;14(1):63-71; discussion 72-3. Review.

PMID:
10069409
9.

Treatment of intermittent claudication: cilostazol.

Collins P, Brittenden J.

Hosp Med. 2004 Aug;65(8):466-70. Review.

PMID:
15330347
10.

Cilostazol for peripheral arterial disease.

Robless P, Mikhailidis DP, Stansby GP.

Cochrane Database Syst Rev. 2007 Jan 24;(1):CD003748. Review. Update in: Cochrane Database Syst Rev. 2008;(1):CD003748.

PMID:
17253494
11.

Comparative effects of cilostazol and other therapies for intermittent claudication.

Dawson DL.

Am J Cardiol. 2001 Jun 28;87(12A):19D-27D. Review.

PMID:
11434896
12.

Evidence-based symptom relief of intermittent claudication: efficacy and safety of cilostazol.

Donnelly R.

Diabetes Obes Metab. 2002 Mar;4 Suppl 2:S20-5. Review.

PMID:
12180354
13.

Systematic review of the efficacy of cilostazol, naftidrofuryl oxalate and pentoxifylline for the treatment of intermittent claudication.

Stevens JW, Simpson E, Harnan S, Squires H, Meng Y, Thomas S, Michaels J, Stansby G.

Br J Surg. 2012 Dec;99(12):1630-8. doi: 10.1002/bjs.8895. Epub 2012 Oct 3. Review.

PMID:
23034699
14.

Cilostazol: treatment of intermittent claudication.

Reilly MP, Mohler ER 3rd.

Ann Pharmacother. 2001 Jan;35(1):48-56. Review.

PMID:
11197586
15.

Cilostazol for peripheral arterial disease.

Robless P, Mikhailidis DP, Stansby GP.

Cochrane Database Syst Rev. 2008 Jan 23;(1):CD003748. doi: 10.1002/14651858.CD003748.pub3. Review. Update in: Cochrane Database Syst Rev. 2014;10:CD003748.

PMID:
18254032
16.

Cilostazol (pletal): a dual inhibitor of cyclic nucleotide phosphodiesterase type 3 and adenosine uptake.

Liu Y, Shakur Y, Yoshitake M, Kambayashi Ji J.

Cardiovasc Drug Rev. 2001 Winter;19(4):369-86. Review.

PMID:
11830753
17.

Treatment of intermittent claudication with pentoxifylline and cilostazol.

Tjon JA, Riemann LE.

Am J Health Syst Pharm. 2001 Mar 15;58(6):485-93; quiz 494-6. Review.

PMID:
11286146
18.
19.

Drug therapy for improving walking distance in intermittent claudication: a systematic review and meta-analysis of robust randomised controlled studies.

Momsen AH, Jensen MB, Norager CB, Madsen MR, Vestersgaard-Andersen T, Lindholt JS.

Eur J Vasc Endovasc Surg. 2009 Oct;38(4):463-74. doi: 10.1016/j.ejvs.2009.06.002. Epub 2009 Jul 7. Review.

20.

The role of cilostazol in the treatment of intermittent claudication.

Barnett AH, Bradbury AW, Brittenden J, Crichton B, Donnelly R, Homer-Vanniasinkam S, Mikhailidis DP, Stansby G.

Curr Med Res Opin. 2004 Oct;20(10):1661-70. Review.

PMID:
15462700

Supplemental Content

Support Center